|
|
|
| Analysis of research hotspots of venous infusion port nursing in China based on bibliometrics |
| CHEN Li1 HAN Ling2 REN Yuyan1▲ |
| 1.Department of Nursing, Qinghai Provincial Cancer Hospital the Fifth People’s Hospital of Qinghai Province, Qinghai Province, Xining 810007, China; 2.Department of Endocrinology, the Fifth People’s Hospital of Qinghai Province, Qinghai Province, Xining 810007, China |
|
|
|
Abstract Objective To analyze the hotspots of nursing research related to intravenous infusion ports by bibliometrics in China. Methods Using “infusion port” and “nursing” as the search terms, the database was searched in CNKI, Wanfang, VIP, and other databases, and the period was set from the establishment of the database to December 2021. The data was exported in RefWorks format, and the CNKI literature visualization analysis system, Excel, and other software were used to draw the total number of papers published, the statistics of the number of published papers per unit, the distribution map of fund support, the co-occurrence map of keywords, the map of author cooperation network, and the map of literature mutual citation network. Results From 1998 to 2021, there were a total of 1 424 related literatures, of which 71 were funded by various levels of funds. The institution with the largest number of publications was the Fourth Hospital of Hebei Medical University, and the word with the highest frequency of keyword co-occurrence was “internal jugular vein”. The most active author of collaborative papers was Zhou Yingfeng (Fudan University), and the most frequently cited document was the “Code of Practice for Intravenous Treatment Nursing Techniques” led by the former National Health Commission in 2013. Conclusion This study analyzes the current status and hotspots in the field of VAP nursing research in China, and has certain reference significance for related nursing staff.
|
|
|
|
|
|
[1] El-Balat A，Schmeil I，Karn T，et al. Catheter-related complications of subcutaneous implantable venous access devices in breast cancer patients [J]. In Vivo，2018，32（5）：1275-1281.
[2] Shin HJ，Na HS，Koh WU，et al. Complications in internal jugular vs subclavian ultrasound-guided central venous catheterization：a comparative randomized trial [J]. Intensive Care Med，2019，45（7）：968-976.
[3] Li G，Zhang Y，Ma H，et al. Arm port vs chest port：a systematic review and meta-analysis [J]. Cancer Manag Res，2019， 11（1）：6099-6112.
[4] Bai XM，Wang J，Zhou Y，et al. Totally implantable venous access devices：the supraclavicular percutaneous approach and early complications [J]. J Cancer Res Ther，2020，16（7）：1575-1581.
[5] Schreckenbach T，Münch I，El Youzouri H，et al. The safety level of total central venous access port implantation performed by residents [J]. J Surg Educ，2019，76（1）：182-192.
[6] Gu J，Wei G，Li L，et al. Catheter allotopia with totally implantable access port：a report of three cases and literature review [J]. Clin Case Rep，2021，9（1）：128-132.
[7] Busch JD，Vens M，Herrmann J，et al. Material failure of silicone catheter lines：a retrospective review of partial and complete ruptures in 553 patients [J]. AJR Am J Roentgenol，2017，208（2）：464-469.
[8] WS/T 433-2013，静脉治疗护理技术操作规范[S].北京：中华人民共和国国家卫生和计划生育委员会，2013.
[9] Pinelli F，Cecero E，Deglinnocenti D，et al. Infection of totally implantable venous access devices：a review of the literature [J]. J Vasc Access，2018，19（6）：230-242.
[10] 中心静脉通路上海协作组，上海市抗癌协会.实体肿瘤聚焦诊疗专委会血管通路专家委员会.完全植入式输液港上海专家共识（2019）[J].介入放射学杂志，2019，28（12）：1123-1128.
[11] 徐绍莲，臧谋红，唐瑭，等.肿瘤化疗患者植入式静脉输液港与PICC并发症发生情况Meta分析[J].护理学报，2020，27（3）：37-42.
[12] 张进泓，罗凤.3380例乳腺癌患者放置完全植入式静脉输液港化疗的并发症分析[J].中华乳腺病杂志（电子版），2019，13（6）：350-355.
[13] 吴孝红，陈惜遂，张红，等.三种路径植入静脉输液港安全性的Meta分析[J].中华护理杂志，2019，54（10）：1551- 1558.
[14] 范海燕，陈显春，王寅欢，等.乳腺癌患者输液港导管异位后安全性探讨[J].局解手术学杂志，2020，29（7）：586- 589.
[15] 韦文姜，李立恒，杜瑜丹，等.静脉输液港植入全程“可视化”的优势[J].中国临床医学影像杂志，2019，30（5）：355-359.
[16] 刘军，陆游，姜浩，等.双导向技术引导下三种路径植入输液港的对比分析[J].中华医学杂志，2020，100（17）：1332-1335.
[17] 王影新，刘飞，赵璇，等.乳腺癌化疗患者不同部位植入输液港的对比研究[J].中华护理杂志，2019，54（6）：917- 921.
[18] 杨进，黄君华，李炳军，等.超声引导调整植入式静脉输液港导管异位1例[J].中国介入影像与治疗学，2020， 17（9）：573-574.
[19] 徐海萍，汪静雯，丁晓慧，等.心电图引导手臂输液港静脉导管头端精准定位111例实证研究[J].中华肿瘤防治杂志，2019，26（23）：1800-1804.
[20] 周浩，张艳，李兰，等.体外测量法结合腔内心电定位技术确定上臂式输液港导管尖端位置的临床研究[J].实用医院临床杂志，2020，17（6）：162-164.
[21] 张进泓，罗凤.外周植入式静脉输液港并发症50例分析与处理[J].中国实用外科杂志，2019，39（11）：1216- 1220.
[22] Intagliata E，Basile F，Vecchio R. Totally implantable catheter migration and its percutaneous retrieval：case report and review of the literature [J]. G Chir，2017，37（5）：211-215.
[23] Wang YC，Lin PL，Chou WH，et al. Long-term outcomes of totally implantable venous access devices [J]. Support Care Cancer，2017，25（7）：2049-2054.
[24] Kakkos A，Bresson L，Hudry D，et al. Complication-related removal of totally implantable venous access port systems：Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients [J]. Eur J Surg Oncol，2017，43（4）：689-695.
[25] 王啟瑶，莫霖，李霞，等.颈内静脉与锁骨下静脉植入静脉输液港的有效性和安全性的Meta分析[J].解放军护理杂志，2018，35（22）：34-39. |
|
|
|
